Compound Screening Center

ICE Bioscience's compound screening center provides efficient, high-quality screening services for drug discovery programs of every scale — from focused compound sets to high-throughput campaigns. Our screening center combines automated platforms with validated biochemical and cellular assays to deliver reliable data with fast turnaround.

Screening Services

• High-throughput screening (HTS) of compound libraries
• IC50/EC50 determination and dose-response profiling
• Selectivity and panel screening across target families
• Hit confirmation and hit-to-lead support
• Custom screening cascades tailored to your program

Validated Assay Portfolio

Screening is performed using ICE Bioscience's validated assay portfolio, covering kinases, GPCRs, ion channels, epigenetic targets, nuclear receptors, transporters and cell-based functional readouts. Assay quality is monitored with accepted performance metrics such as Z' factor, and every campaign is delivered with clear, structured data packages.

From Screening to Decision

Screening results can be followed seamlessly by selectivity profiling, safety assessment, DMPK studies and in vivo efficacy testing within ICE Bioscience, keeping your program moving forward without handover delays.

If you would like to learn more about this service or discuss your project, please contact our team for a tailored proposal and quotation.